News from sierra oncology A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 23, 2021, 07:00 ET Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN MATEO, CA, June 23, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

Jun 21, 2021, 07:00 ET Sierra Oncology Announces Completion of Enrollment for MOMENTUM Phase 3 Trial

—Topline data anticipated in Q1 2022 with NDA filing to follow in H2 2022— SAN MATEO, Calif., June 21, 2021 /PRNewswire/ - Sierra Oncology, Inc....

Jun 14, 2021, 07:00 ET Sierra Oncology Hosting KOL Panel Event to Discuss Momelotinib Data Presented at EHA 2021

--Chief Medical Officer Dr. Barbara Klencke, to be joined by leading myelofibrosis experts Drs. Aaron Gerds, Stephen Oh and Srdan Verstovsek-- SAN...

Jun 11, 2021, 03:00 ET Momelotinib Oral Presentation at European Hematology Association Demonstrates Association Between Transfusion Independence and Improved Overall Survival

—Additional poster presentation highlights improved transfusion independence of momelotinib irrespective of baseline degree of anemia, platelet count ...

Jun 03, 2021, 07:00 ET Sierra Oncology Welcomes Two New Independent Directors to its Board

—Georgia Erbez and Christy Oliger bring additional strategy, finance and commercial experience as Sierra prepares for commercialization of...

May 25, 2021, 07:00 ET Sierra Oncology Announces Presentation at Jefferies Healthcare Conference

SAN MATEO, Calif., May 25, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

May 21, 2021, 07:00 ET Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN MATEO, Calif., May 21, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

May 19, 2021, 17:00 ET Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting

—New momelotinib analysis examining the association between transfusion independence and overall survival to be presented— SAN MATEO, Calif., May 19, ...

May 12, 2021, 10:00 ET Sierra Oncology Announces Oral Presentation at European Hematology Association Annual Meeting

– Oral presentation for new momelotinib analysis examines association between transfusion independence and overall survival – – Poster presentation...

May 07, 2021, 07:00 ET Sierra Oncology Reports First Quarter 2021 Results

– Pivotal MOMENTUM Phase 3 Trial Anticipated to Complete Enrollment in June 2021 – – Topline Data Now Expected in Q1 2022 – SAN MATEO, Calif., May 7, ...

Mar 23, 2021, 07:00 ET Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN MATEO, Calif., March 23, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

Mar 11, 2021, 07:00 ET Sierra Oncology Reports 2020 Year End Results

– MOMENTUM Phase 3 Trial on Track to Complete Enrollment in mid-2021 with Top-line Data Anticipated in H1 2022 – – Data Presented Throughout the Year ...

Mar 03, 2021, 07:00 ET Sierra Oncology to Present at Three Upcoming Investor Conferences

—HC Wainwright Life Sciences Conference beginning at 7:00 am ET on March 9th— —Roth Conference at 10:00 am ET on March 15th— —Oppenheimer Healthcare...

Feb 12, 2021, 07:00 ET Sierra Oncology Announces Presentation at LifeSci Partners Precision Oncology Day

SAN MATEO, Calif., Feb. 12, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

Feb 09, 2021, 07:00 ET Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN MATEO, Calif., Feb. 9, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

Jan 05, 2021, 07:00 ET Sierra Oncology to Present at H.C. Wainwright 2021 BioConnect Virtual Conference

VANCOUVER, BC, Jan. 5, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted...

Dec 07, 2020, 10:00 ET Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts

--Retrospective analyses of the Phase 3 SIMPLIFY studies demonstrate safety and activity profile are not impacted by baseline platelet count--...

Dec 05, 2020, 10:30 ET Sierra Oncology Presents Long-term Overall Survival and Sustained Efficacy Outcomes Data for Momelotinib at ASH Annual Meeting

--Momelotinib demonstrates robust overall survival in both JAKi-naïve and patients previously treated with ruxolitinib-- VANCOUVER, BC, Dec. 5, 2020...

Dec 01, 2020, 07:00 ET Sierra Oncology to Host KOL Panel Event to Discuss Updated Phase 3 Myelofibrosis Data Presented at ASH

--Sierra Chief Development Officer Barbara Klencke to be joined by renowned myelofibrosis experts Jean-Jacques Kiladjian, Ruben Mesa and Srdan...

Nov 25, 2020, 07:00 ET Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

VANCOUVER, BC, Nov. 25, 2020 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company focused on the Phase 3 execution,...

Nov 12, 2020, 07:00 ET Sierra Oncology to Present at 2020 Jefferies Virtual London Healthcare Conference

VANCOUVER, BC, Nov. 12, 2020 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company focused on the Phase 3 execution,...

Nov 05, 2020, 08:00 ET Sierra Oncology to Report Momelotinib Long-term Overall Survival Data in Oral Presentation at ASH 2020

- Efficacy data for momelotinib in myelofibrosis patients by baseline platelet levels also to be presented - VANCOUVER, BC, Nov. 5, 2020 /PRNewswire/ ...

Nov 05, 2020, 07:00 ET Sierra Oncology Reports Third Quarter 2020 Results

- MOMENTUM Phase 3 clinical trial enrollment on track; top-line data anticipated in H1 2022 - VANCOUVER, BC, Nov. 5, 2020 /PRNewswire/ - Sierra...

Oct 02, 2020, 07:00 ET Sierra Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, BC, Oct. 2, 2020 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the registration and...

Sep 14, 2020, 07:00 ET Sierra to Present at September Investor Conferences

VANCOUVER, BC, Sept. 14, 2020 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the registration and...